West Announces Second-Quarter 2023 Dividend

West Pharmaceutical Services, Inc. (NYSE: WST) has announced a quarterly dividend of $0.19 per share, payable on May 3, 2023, to shareholders recorded as of April 26, 2023.

Rhea-AI Summary

West Pharmaceutical Services, Inc. (NYSE: WST) has announced a quarterly dividend of $0.19 per share, payable on May 3, 2023, to shareholders recorded as of April 26, 2023. This dividend reflects the company's ongoing commitment to returning value to its shareholders. In fiscal year 2022, West generated $2.89 billion in net sales, marking a significant milestone in its 100-year history of innovation in the injectable solutions market. The company supports pharmaceutical developers with reliable containment and delivery solutions, underscoring its critical role in healthcare.

Positive

• Dividend of $0.19 per share indicates strong shareholder return.
• Generated $2.89 billion in net sales in fiscal year 2022.
• Marks 100 years of innovation and leadership in the injectable solutions market.

Negative

• None.

Argus Session date unavailable

+2.03% session move Open Argus

Details

News Market Reaction – WST

The recorded move for WST in the trading session of this news was +2.03%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

EXTON, Pa., March 3, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announces that the Company's Board of Directors has approved a second-quarter 2023 dividend of $0.19 per share. The dividend will be paid on May 3, 2023, to shareholders of record as of April 26, 2023.

About West 
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 47 billion components and devices each year. 

2023 marks West's 100-year milestone of innovation and the critical role it continues to play in healthcare and the patient experience. Headquartered in Exton, Pennsylvania, West in its fiscal year 2022 generated $2.89 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included in the Standard & Poor's 500 index. For more information, visit www.westpharma.com.

© 2023 West Pharmaceutical Services, Inc. 
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/west-announces-second-quarter-2023-dividend-301761743.html

SOURCE West Pharmaceutical Services, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the dividend amount announced by West Pharmaceutical Services for Q2 2023?

West Pharmaceutical Services announced a dividend of $0.19 per share.

When will the dividend be paid to shareholders?

The dividend will be paid on May 3, 2023.

What is the record date for the dividend payment by West Pharmaceutical Services?

The record date for the dividend payment is April 26, 2023.

How much net sales did West Pharmaceutical Services generate in 2022?

West Pharmaceutical Services generated $2.89 billion in net sales in fiscal year 2022.

What milestone is West Pharmaceutical Services celebrating in 2023?

West Pharmaceutical Services is celebrating its 100-year milestone of innovation.